Clinical Trial Update: A Study to Investigate Ronde-cel Versus Investigator's Choice CD19 CAR T-Cell Therapy [Phase 3]

View source ↗

Summary

A Phase 3 trial compares Ronde-cel CD19 CAR T-cell therapy against investigator's choice CD19 CAR T-cell therapy in adults with large B-cell lymphoma and other …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diffuse Large B-cell Lymphoma
• Non-hodgkin Lymphoma

Drugs mentioned

• Ronde-cel

Snippet

Sponsor: Lyell Immunopharma, Inc. | Conditions: Large B-cell Lymphoma, Lymphoma, B-Cell | Phase 3 | Status: RECRUITING